Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology
Neal I. Lindeman(Brigham and Women's Hospital), Philip T. Cagle(Houston Methodist), Mary Beth Beasley, Dhananjay Chitale(Henry Ford Hospital), Sanja Đačić(University of Pittsburgh Medical Center), Giuseppe Giaccone(National Institutes of Health Clinical Center), Robert B. Jenkins(Mayo Clinic), David J. Kwiatkowski(Brigham and Women's Hospital), Juan‐Sebastian Saldivar(City Of Hope National Medical Center), Jeremy A. Squire(Queen's University), Erik Thunnissen(Amsterdam UMC Location VUmc), Marc Ladanyi(Memorial Sloan Kettering Cancer Center)
Cited by 1,281Open Access